Skip to main content

Table 1 Scheme of the study

From: Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters

TIMEPOINT of visit/assessment

Baseline

15 days (call interview)

3 months

6 months- end of the study

Enrollment

   Information and informed consent

   

   Randomization-allocation

   

Interventions

   Probiotic Intervention

   Placebo Intervention

Assessment

   Physical examination including anthropometric measures and abdominal tenderness

 

   Drug compliance and adverse event assessment

 

   Weekly food diaries

  

   ADI-R

   

Outcome measures

   ADOS 2

  

   CARS

  

   RBS-R

 

   Sensory Profile

 

   SCQ

 

   GI Severity Index

 

   CBCL 1.5-5

 

   PSI

 

   VABS-II

  

   Mc Arthur-CDI

 

   GMDS-ER

  

   Blood sample: LPS, Leptin, Resistin, TNF-α, IL-6, PAI-1

  

   Urinary sample: Phtalates

 

   Fecal sample: Calprotectin

 

   High-density EEG registration: power, asymmetry index and coherence in the different frequency bands

  

  1. Legend: ADI-R Autism Diagnostic Interview-Revised, ADOS-2 Autism Diagnostic Observation Schedule- Second Edition, CARS Childhood Autism Rating Scale, RBS-R Repetitive Behavior Scale-Revised, SCQ Social Communication Questionnaire, GI Severity Index Gastro-Intestinal Severity Index, CBCL 1.5-5 Child Behavior Checklist 1.5-5, PSI Parenting Stress Index, VABS-II Vineland Adaptive Behavior Scale-Second Edition, Mc Arthur-CDI MacArthur-Bates Communicative Development Inventories, GMDS-ER Griffiths Mental Development Scale-Extended Revised, LPS Lipopolysaccharide, TNF–α Tumor Necrosis Factor-α, IL-6 Interleukin-6, PAI–1 Plasminogen Activator Inhibitor-1, EEG Electroencephalography